![]() |
市場調查報告書
商品編碼
1403384
全球醫學高光譜影像市場預測(-2030):按產品、技術、應用、最終用戶和地區分析Medical Hyperspectral Imaging Market Forecasts to 2030 - Global Analysis By Product, Technology, Application, End User and By Geography |
2023年全球醫學高光譜影像市場規模將達18億美元,預計2030年將達49億美元,預測期內複合年成長率為15.1%。
高光譜影像(HSI)是一種新開發的醫學影像技術,特別適用於影像導引手術和疾病辨識。 HSI獲得了具有兩個空間維度和一個頻譜維度的超立方體資料集。透過空間分辨頻譜成像,HSI 提供有關組織生理學、形狀和成分的診斷資訊。
根據國際癌症研究機構(IARC)的數據,2020年報告了超過190萬例大腸新病例,93萬人死亡。預計到 2040 年,這一統計數字以年度為基礎將分別成長 63%(320 萬人)和 73%(160 萬人)。
癌症盛行率上升
醫學高光譜影像的主要應用之一是固態腫瘤的檢測。癌症診斷的非侵入性、消除組織切片檢查以及提供即時的顯影劑診斷特徵是與高光譜影像相關的一些主要優點。此外,由於癌症發生率上升刺激了對醫學高光譜影像的需求不斷增加,高光譜影像市場也在不斷成長。
醫療高光譜影像系統的成本過高
高光譜遙測影像系統的成本包括高光譜遙測相機、光源、軟體、反射面板、顯微鏡和其他配件的價格。然而,高光譜遙測相機和顯微鏡的成本限制了衛生系統在既定預算內提供治療的能力。例如,高光譜遙測相機由中國Optosky生產,價格從45,000美元到48,800美元不等。在美國,該計劃的起價通常為 50,000 美元。
越來越多的研究探索醫療應用
由於高光譜遙測系統仍處於探索醫學應用的階段,因此正在針對疾病診斷進行大量研究。根據 2023 年 1 月 NCBI 的研究報告,高光譜遙測影像可用於預測糖尿病足潰瘍的癒合速度。根據這項研究的結果,高光譜遙測影像是一種廉價的測試,可以輕鬆涵蓋常規臨床實踐,並可能為糖尿病足潰瘍的癒合潛力提供重要的見解。
大規模資料存儲
資料的複雜性需要大量的儲存空間,限制了市場的擴展,對於企業來說並不便宜。例如,根據 2022 年 4 月 Hindawi 的一篇論文,大量資料儲存為與機器學習和深度學習相結合的高光譜遙測影像系統帶來了很高的空間複雜性。然而,由於需要測試和學習大量的 HSI 原始資料,因此非常耗時。這將限制整個預測期內的市場成長。
自2019年12月爆發以來,疫情已蔓延至全球超過213個國家,世界衛生組織於2020年3月宣布進入公共衛生緊急狀態。 COVID-19大流行導致美國、中國、日本、印度和德國等主要國家長期封鎖,導致非關鍵產品的製造設施關閉。結果,世界各地大多數工業設施被迫關閉或停止生產。
預計相機行業在預測期內將是最大的
相機行業佔據最大佔有率,因為成像設備對於改善治療方法和診斷準確性至關重要。由於高光譜遙測相機可以記錄的波長範圍很廣,因此可以詳細分析生物組織並改善疾病的檢測。此外,高光譜影像在即時組織識別、疾病檢測和手術指導等應用中的越來越多的使用也促進了需求的成長。這些相機為醫療專業人員提供了對組織成分的獨特見解,有助於早期檢測和治療計劃。
預計眼科在預測期內複合年成長率最高
由於醫學高光譜影像具有改變眼科診斷的特殊能力,預計眼科產業將實現獲利成長。眼科醫學高光譜影像可以全面了解視網膜組織,並且能夠準確診斷各種眼科疾病,例如老齡化黃斑部病變和糖尿病視網膜病變。此外,這種從眼組織提取頻譜資訊的技術可以幫助早期診斷異常,並為客製化治療提供有用的資訊。
由於醫學的進步和技術應用的增加,亞太地區佔據了最大的佔有率。該地區不斷成長的人口和不斷增加的醫療基礎設施投資正在推動對最新醫學成像技術的需求。高光譜影像能夠提供廣泛的頻譜資訊,以提高疾病診斷和外科手術的準確性,這與該地區對尖端醫療技術的日益關注不謀而合。此外,癌症和心血管疾病等慢性疾病的流行增加了對尖端診斷工具的需求,而高光譜遙測影像提供了突破性的治療方法。
由於政府努力支持中國、印度和日本等國家的醫療基礎設施和研究能力,預計亞太地區將保持良好的成長。該地區強大的研究社群以及學術機構和產業相關人員之間的合作不斷推動創新。此外,醫療專業人員對高光譜影像在眼科、皮膚科和腫瘤學等廣泛醫療應用中的優勢的專業知識不斷成長,也推動了高光譜成像的廣泛接受。
According to Stratistics MRC, the Global Medical Hyperspectral Imaging Market is accounted for $1.8 billion in 2023 and is expected to reach $4.9 billion by 2030 growing at a CAGR of 15.1% during the forecast period. Hyperspectral imaging (HSI), a newly developed imaging method used in medicine, is especially useful for image-guided surgery and the identification of illnesses. The hypercube dataset, which has two spatial dimensions and one spectral dimension, is acquired through HSI. Through spatially resolved spectrum imaging, HSI provides diagnostic information on tissue physiology, shape, and composition.
According to the International Agency for Research on Cancer (IARC), in 2020, more than 1.9 million new cases of colorectal were reported leading to 930,000 deaths. The mentioned statistics are predicted to increase by 63% (3.2 million new cases) and 73% (1.6 million), respectively, by 2040 on an annual basis.
One of the main uses of medical hyperspectral imaging is solid tumor detection. The non-invasive nature of cancer diagnosis, the omission of tissue biopsies, and the provision of diagnostic signatures without the requirement for a real-time contrast agent are some of the primary benefits linked to hyperspectral imaging. Furthermore, the market is growing as a result of the rising demand for medical hyperspectral imaging spurred on by the rising incidence of cancer.
The price of the hyperspectral camera, light sources, software, reflectance panel, microscope, and additional accessories have been included in the cost of a hyperspectral imaging system. However, the expense of hyperspectral cameras and microscopes strains the healthcare system's ability to provide treatment within the allotted budget. For instance, hyperspectral cameras are produced by the Chinese business Optosky, and they cost between $45,000 and $48,800. This method frequently begins at USD 50,000 and rises upwards in the US.
As hyperspectral systems are still in their exploratory stages of usage in medicine, many studies are being conducted to diagnose diseases. A January 2023 NCBI research report states that hyperspectral imaging can be used to forecast the rate at which diabetic foot ulcers will heal. According to the study's results, hyperspectral imaging is an inexpensive test that can be readily included in regular clinical practice and may offer significant insights into DFU's capacity to heal.
Due to the complexity of data, large storage areas are required, which limits market expansion and is not inexpensive for businesses. For instance, bulk data storage causes high space complexity for hyperspectral imaging systems combined with machine and deep learning, according to a Hindawi paper from April 2022. However, it takes a long time because of the massive amount of raw HSI data that needs to be tested and trained. This restricts market growth throughout the projection period.
The World Health Organization declared the disease a public health emergency in March 2020 after it spread to over 213 nations worldwide since the outbreak in December 2019. The COVID-19 pandemic resulted in a protracted lockdown in major nations such as the United States, China, Japan, India, and Germany, which led to the suspension of manufacturing facilities that do not correspond to critical products. It caused the majority of industrial facilities worldwide to either close or halt their production.
Because imaging instruments are essential for improving therapeutic treatments and diagnostic accuracy, the cameras portion held the largest share. The wide range of wavelengths that hyperspectral cameras can record enables it feasible to analyze biological tissues in enormous detail and improve the detection of disorders. Additionally, the growing use of hyperspectral imaging for applications like real-time tissue distinction, illness detection, and surgical guidance is contributing to the demand increase. These cameras help with early detection and treatment planning by providing healthcare professionals with unique insights into tissue composition.
Because of the special powers of medical hyperspectral imaging to transform ocular diagnostics, the ophthalmology sector is predicted to grow profitably. Medical hyperspectral imaging in ophthalmology provides comprehensive insights into the retinal tissue, allowing for the accurate diagnosis of a variety of eye disorders, such as age-related macular degeneration and diabetic retinopathy. Moreover, the technology's capacity to extract spectral information from ocular tissues helps in the early diagnosis of abnormalities and offers useful information for customized therapies.
Owing to advancements in healthcare and growing technological usage, the Asia-Pacific region held the largest share. Modern medical imaging technologies are in high demand due to the region's expanding population and rising investments in healthcare infrastructure. The capacity of hyperspectral imaging to offer extensive spectral information for improved diagnosis of illnesses and surgical accuracy is in accordance with the region's increasing focus on cutting-edge medical technology. In addition, the prevalence of chronic illnesses like cancer and cardiovascular disorders has increased the demand for cutting-edge diagnostic tools, with hyperspectral imaging being offered as a revolutionary treatment.
Asia Pacific region is expected to hold lucrative growth due to government initiatives in nations like China, India, and Japan that support healthcare infrastructure and research abilities. Technological innovation is continuously driven in the region by a robust research community and collaborations between academic institutions and industry participants. Furthermore, widespread acceptance has been fueled by rising expertise among medical professionals of the benefits of hyperspectral imaging in a wide range of medical applications, such as ophthalmology, dermatology, and oncology.
Some of the key players in Medical Hyperspectral Imaging market include Applied Spectral Imaging Inc, Bayspec Inc, Cubert GmbH, HyVista Corporation Pty Ltd, Inno-Spec GmbH, ITRES Research Limited, Norsk Elektro Optikk AS, Photonics Science Co, Resonon, Inc, Si-Ware Systems, Specim Spectral Imaging Ltd., Surface Optics Corporation and Tetracam Inc.
In July 2022, Headwall Photonics announced the acquisition of Holographix LLC to expand its manufacturing capabilities to address future growth.
In June 2022, Resonon Inc. announced the launch of Pika IR-L and IR-L+ hyperspectral cameras (925 - 1700 nm).